Non-Invasive Surgical Wound Closure Market Trends

Market Trends of Non-Invasive Surgical Wound Closure Industry

The Adhesives Segment is Expected to Hold a Significant Market Share Over the Forecast Period

• Adhesives offer a less invasive and virtually painless alternative to traditional wound closure methods such as sutures and staples. Patients often prefer adhesive-based closures as they avoid the discomfort associated with needle and thread or metal staples. Adhesives can facilitate faster wound closure. They are easy to apply and require less time than sutures or staples, reducing the overall duration of surgery and potentially lowering the risk of infection. All these characteristics make the adhesives segment the dominant market.
• Furthermore, as the use of tissue adhesives rises, there is a corresponding surge in demand for non-invasive methods of surgical wound closure. Tissue adhesives offer several advantages over traditional methods, such as sutures or staples, including reduced procedure time, minimal tissue trauma, and improved cosmetic outcomes. For instance, an article published by Springer Nature in June 2023 stated that the development of new tissue adhesives (TAs) for various applications has garnered significant attention. These adhesives offer benefits such as shorter surgery times, less pain, leakage prevention, and the avoidance of removal procedures. Due to the discomfort that can be caused by sutures, there has been increased interest in sutureless methods for wound closure, despite sutures being widely used due to their simplicity and quick application. Therefore, as more healthcare providers recognize these benefits, there is a growing preference for non-invasive techniques, which in turn drives the demand for products in the non-invasive surgical wound closure market.
• There has been an increase in product approvals and launches concerning the adhesive segment. This is something that can be considered as a boosting factor for the market. For instance, in February 2023, 3M launched a new medical adhesive. It was an advanced medical adhesive that could stick to the skin for up to 28 days. This reflects the strategies of the companies to improvise their adhesive product portfolio. This would help in propelling the growth of this segment in the forecasted period.
• Adhesives are less likely to cause allergic reactions compared to some suture materials, which can be made from materials like silk or metal. This can be particularly important for patients who are sensitive or have allergies. These factors contribute to the significant share of adhesives in this market and are expected to boost the growth of the market during the forecast period.

North America is Expected to Hold a Significant Market Share During the Forecast Period

• During the forecast period, North America is anticipated to register a substantial growth rate in the non-invasive surgical wound closure market. This can be linked to elements like the rise in surgical procedures and the growing population of elderly people.
• The overall rise in surgical procedures, including both elective and non-elective surgeries, is a significant driver for the non-invasive surgical wound closure market. As per one of the articles published by Vianam Healthtech Private Limited in July 2023, approximately 2,00,000 heart bypass surgeries are performed in the United States in a year. Similarly, according to the University of Ottawa Heart Institute, in October 2023, this heart institute had around 1,900 heart procedures performed annually in Canada. The market for non-invasive surgical wound closure is rising in this region as a result of preferences for non-invasive options and the rising number of surgical procedures performed in North America. Patients and healthcare providers alike prefer less invasive procedures, and non-invasive wound closure methods align well with this trend.
• The rise in the number of product approvals through the US FDA fuels the growth of the market in this region. For instance, Advanced Medical Solutions Group PLC's LiquiBand XL, a novel device that can cover longer wounds than conventional LiquiBand products, was granted FDA 510(k) approval in May 2022. The device consists of LiquiBand glue to reinforce the closure and stop infection, together with surgical mesh to close the wound. Developments like these are expected to boost the growth of this market in North America.
• Therefore, the market studied is expected to expand in North America as a result of the aforementioned factors, such as the rising number of surgical procedures and the surge in the number of product approvals in this region.